Cargando…
11, 13-Dehydro Lactone Moiety in Gynecologic Cancer Cells
BACKGROUND: To study the anti-cancer effect of isoalantolactone, a sesquiterpene lactoneisolated from the roots of Inula heleniumon human gynecologic cancer cells. METHODS: A structure-activity relationship experiment was designed to identify the functional moiety of isoalantolactone for its signifi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917499/ https://www.ncbi.nlm.nih.gov/pubmed/33680997 http://dx.doi.org/10.18502/ijph.v49i11.4726 |
_version_ | 1783657713273667584 |
---|---|
author | LIU, Yibing MENG, Qingju JING, Li FENG, Li ZHOU, Zhiguo NI, Zhiyu |
author_facet | LIU, Yibing MENG, Qingju JING, Li FENG, Li ZHOU, Zhiguo NI, Zhiyu |
author_sort | LIU, Yibing |
collection | PubMed |
description | BACKGROUND: To study the anti-cancer effect of isoalantolactone, a sesquiterpene lactoneisolated from the roots of Inula heleniumon human gynecologic cancer cells. METHODS: A structure-activity relationship experiment was designed to identify the functional moiety of isoalantolactone for its significant anti-cancer activity. Five gynecologic cancer cell lines were treated with isoalantolactone. Cell proliferation was determined by MTT assay in vitro and cell apoptosis by flow cytometry. RESULTS: We found isoalantolactone strongly inhibited the cell proliferationofHEC-1, HAC-2, HOC-21, and HeLa cells. Its inhibitory effect was comparable to that of well-known chemotherapeutic agents, cisplatin and taxol. Furthermore, isoalantolactone induced apoptosis in HeLa cells via caspase. On the contrary, its 11, 13-dihydro derivatives had much weaker anti-proliferative activities than the parent compound. CONCLUSION: Isoalantolactone exhibited strong anti-proliferative activities and apoptosis-inducing effects on gynecologic cancer cells. The 11, 13-dehydro lactone moiety was critical for its anti-proliferative activity. |
format | Online Article Text |
id | pubmed-7917499 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-79174992021-03-04 11, 13-Dehydro Lactone Moiety in Gynecologic Cancer Cells LIU, Yibing MENG, Qingju JING, Li FENG, Li ZHOU, Zhiguo NI, Zhiyu Iran J Public Health Original Article BACKGROUND: To study the anti-cancer effect of isoalantolactone, a sesquiterpene lactoneisolated from the roots of Inula heleniumon human gynecologic cancer cells. METHODS: A structure-activity relationship experiment was designed to identify the functional moiety of isoalantolactone for its significant anti-cancer activity. Five gynecologic cancer cell lines were treated with isoalantolactone. Cell proliferation was determined by MTT assay in vitro and cell apoptosis by flow cytometry. RESULTS: We found isoalantolactone strongly inhibited the cell proliferationofHEC-1, HAC-2, HOC-21, and HeLa cells. Its inhibitory effect was comparable to that of well-known chemotherapeutic agents, cisplatin and taxol. Furthermore, isoalantolactone induced apoptosis in HeLa cells via caspase. On the contrary, its 11, 13-dihydro derivatives had much weaker anti-proliferative activities than the parent compound. CONCLUSION: Isoalantolactone exhibited strong anti-proliferative activities and apoptosis-inducing effects on gynecologic cancer cells. The 11, 13-dehydro lactone moiety was critical for its anti-proliferative activity. Tehran University of Medical Sciences 2020-11 /pmc/articles/PMC7917499/ /pubmed/33680997 http://dx.doi.org/10.18502/ijph.v49i11.4726 Text en Copyright © 2020 Liu et al. Published by Tehran University of Medical Sciences https://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited. |
spellingShingle | Original Article LIU, Yibing MENG, Qingju JING, Li FENG, Li ZHOU, Zhiguo NI, Zhiyu 11, 13-Dehydro Lactone Moiety in Gynecologic Cancer Cells |
title | 11, 13-Dehydro Lactone Moiety in Gynecologic Cancer Cells |
title_full | 11, 13-Dehydro Lactone Moiety in Gynecologic Cancer Cells |
title_fullStr | 11, 13-Dehydro Lactone Moiety in Gynecologic Cancer Cells |
title_full_unstemmed | 11, 13-Dehydro Lactone Moiety in Gynecologic Cancer Cells |
title_short | 11, 13-Dehydro Lactone Moiety in Gynecologic Cancer Cells |
title_sort | 11, 13-dehydro lactone moiety in gynecologic cancer cells |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917499/ https://www.ncbi.nlm.nih.gov/pubmed/33680997 http://dx.doi.org/10.18502/ijph.v49i11.4726 |
work_keys_str_mv | AT liuyibing 1113dehydrolactonemoietyingynecologiccancercells AT mengqingju 1113dehydrolactonemoietyingynecologiccancercells AT jingli 1113dehydrolactonemoietyingynecologiccancercells AT fengli 1113dehydrolactonemoietyingynecologiccancercells AT zhouzhiguo 1113dehydrolactonemoietyingynecologiccancercells AT nizhiyu 1113dehydrolactonemoietyingynecologiccancercells |